Active · per the CBE, 31 October 2026

SANOPHAR

BE0471640823

Rechtspersoon Public limited company 2 establishments

SANOPHAR is a pharmacy in Menen. Public Limited, started on 14 April 2000, 2 establishments.

Volkslaan 111, 8930 Menen

Behind the company: GEROFARMA BV, VEMAPHAR BV.

Active for

26 year, 6 months

Financials

Financial year 2025

SANOPHAR from Menen, company number BE0471640823, closed financial year 2025 with a result of € 98,632 after tax. For that financial year SANOPHAR recorded a gross margin of € 352,673 and equity of € 477,087. Compared with financial year 2024, the result moved from € 173,715 to € 98,632. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 477,087

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 98,632

▼ 43% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 256,637

▲ 9% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 98,000 paid out

99 % of the profit went to the shareholders, mostly to VEMAPHAR (50 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.9

▲ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 224,081

▲ 9% vs 2024

€ 77,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,820

▼ 40% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 13 years to go

€ 156,000

▼ 7% vs 2024

€ 12,000 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 135,927

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,082

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 647,324 € 366,444 € 406,062 € 352,673 ▼ 13%
Profit after taxes € 155,860 € 112,060 € 173,715 € 98,632 ▼ 43%
Equity € 476,180 € 476,240 € 476,455 € 477,087
Total debts € 859,039 € 761,747 € 707,771 € 690,270 ▼ 2%
Cash € 300,859 € 376,866 € 235,471 € 256,637 ▲ 9%
Land & buildings € 169,858 € 391,548 € 386,852 € 378,156 ▼ 2%
Retained profit € 120,407 € 120,468 € 120,682 € 121,314 ▲ 1%
Dividend € 155,000 € 112,000 € 173,500 € 98,000 ▼ 44%
Bank debt € 15,050 € 180,000 € 168,000 € 156,000 ▼ 7%
Balance sheet total € 1,335,219 € 1,237,988 € 1,184,226 € 1,167,356 ▼ 1%
Employees (FTE) 6.1 2.8 2.7 2.9 ▲ 0.2

Key figures of SANOPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SANOPHAR?

What happened at SANOPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 98,632 (▼ 43% vs 2024). Source: NBB ↗
  • VEMAPHAR BV became a director. NBB
  • New establishment in Menen. KBO
  • New establishment in Menen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 155,860 profit in 2022 to € 98,632 profit in 2025.

Paid € 7,636 in corporate taxes since 2022.

Best year ever: 2024, with € 173,715 profit.

On average € 121,600 of value added per employee in 2025.

Management

The stake of VEMAPHAR, geroFarma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

SANOPHAR

Behind SANOPHAR are GEROFARMA BV and VEMAPHAR BV. The shares are held by VEMAPHAR (50%) and geroFarma (50%).

Directors

According to the 2025 annual accounts

GEROFARMA BV

Director · represented by Loosveldt Fien

Also active at: Farmave

VEMAPHAR BV

Director · represented by Verbeke Koen

Also active at: Apotheek Popelier, APOTHEEK MAERTENS, Farmave

since 2020

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Volkslaan 111

8930 Menen

2.186.047.329

Bruggestraat 98

8930 Menen

Active since 5 June 2008

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0471.640.823
VAT number
BE 0471.640.823
Registered office
Volkslaan 111, 8930 Menen
Names & denominations
SANOPHAR
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
14 April 2000
Peppol
Active · Active since 4 Jun 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What does SANOPHAR do?
SANOPHAR is a pharmacy in Menen. Public Limited, started on 14 April 2000, 2 establishments.
What is the address of SANOPHAR?
The registered office of SANOPHAR is located at Volkslaan 111, 8930 Menen.
Is SANOPHAR still active?
Yes. According to the CBE (31 October 2026) SANOPHAR is active, legal situation “Normale toestand”, started on 14 April 2000.
Is SANOPHAR registered on Peppol?
Yes, SANOPHAR is registered on the Peppol network with ID 0208:0471640823.
What is the enterprise number of SANOPHAR?
The enterprise number of SANOPHAR is BE0471640823.
When was SANOPHAR founded?
SANOPHAR was founded on 14 April 2000.